Abstract
Patients of Tuberculosis have poor treatment outcome with high mortality. Immunodeficiency appears to be an important risk factor in the development of multi drug resistance (MDR) and extensively drug resistance (XDR) tuberculosis. Mesenchymal stromal cell (MSCs) having immunomodulatory effect, have been used as adjunct autologous treatment. Thereby, it helps in transforming chronic inflammation into productive immune response. Stem cells therapy is based on the principle, that it migrates to the site of injury and forms tissue specific cell type that can replace the damaged tissue. Autologous MSCs have been used as an adjunct treatment in MDR TB in the lungs for accelerating clearance of pathogenic bacteria and early recovery. It appears to be a promising procedure for enhancing the efficacy of anti-TB therapy in MDR and XDR subjects.
Keywords: Multi-drug resistance, extremely drug resistance, tuberculosis, mesenchymal stem cell therapy.
Current Respiratory Medicine Reviews
Title:Stem Cells in MDR-TB and XDR - TB
Volume: 10 Issue: 4
Author(s): Vijay K. Arora, Paramjit S. Dhot and P. Singhal
Affiliation:
Keywords: Multi-drug resistance, extremely drug resistance, tuberculosis, mesenchymal stem cell therapy.
Abstract: Patients of Tuberculosis have poor treatment outcome with high mortality. Immunodeficiency appears to be an important risk factor in the development of multi drug resistance (MDR) and extensively drug resistance (XDR) tuberculosis. Mesenchymal stromal cell (MSCs) having immunomodulatory effect, have been used as adjunct autologous treatment. Thereby, it helps in transforming chronic inflammation into productive immune response. Stem cells therapy is based on the principle, that it migrates to the site of injury and forms tissue specific cell type that can replace the damaged tissue. Autologous MSCs have been used as an adjunct treatment in MDR TB in the lungs for accelerating clearance of pathogenic bacteria and early recovery. It appears to be a promising procedure for enhancing the efficacy of anti-TB therapy in MDR and XDR subjects.
Export Options
About this article
Cite this article as:
K. Arora Vijay, S. Dhot Paramjit and Singhal P., Stem Cells in MDR-TB and XDR - TB, Current Respiratory Medicine Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/1573398X11666150109223613
DOI https://dx.doi.org/10.2174/1573398X11666150109223613 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and Applications of Chalcogenoamide: Thio-, Seleno- and Telluroamides
Current Organic Synthesis Antimicrobial, Antitumor and Side Effects Assessment of a Newly Synthesized Tamoxifen Analog
Current Topics in Medicinal Chemistry The Role of Exosomes in Infectious Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Association of N-Acetyltransferase-2 Genotypes and Anti-Tuberculosis Induced Liver Injury: First Case-Controlled Study from Iran
Current Drug Safety Recent Advances in the Development of Anti-Infective Prophylactic and/or Therapeutic Agents Based on Toll-Like Receptor (TLRs)
Recent Patents on Anti-Infective Drug Discovery Adherence to Anti-Retroviral Therapy in North Central Nigeria
Current HIV Research Editorial [Hot Topic: Tuberculosis; Opportunities for Treatment Optimization (Executive Guest Editor: Jan-Willem C. Alffenaar)]
Current Pharmaceutical Design Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs
Current Drug Targets Applications of Polymeric Nanocapsules in Field of Drug Delivery Systems
Current Drug Discovery Technologies Candidate Susceptibility Genes in Alzheimers Disease Are at High Risk for Being Forgotten - They Dont Give Peace of Mind...
Current Drug Metabolism New Strategies and Paradigm for Drug Target Discovery: A Special Focus on Infectious Diseases Tuberculosis, Malaria, Leishmaniasis, Trypanosomiasis and Gastritis
Infectious Disorders - Drug Targets Biomarker Discovery in Clinical Proteomics: Strategies for Exposing Low Abundant Proteins
Current Proteomics Vaccine Therapy Update for Pregnant, Immunocompromised, and Chronic Diseases Patients
Recent Patents on Inflammation & Allergy Drug Discovery Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews Natural Products: Key Prototypes to Drug Discovery Against Neglected Diseases Caused by Trypanosomatids
Current Medicinal Chemistry Editorial [Hot Topic: In Silico (Guest Editor: Alexandre G. de Brevern)]
Infectious Disorders - Drug Targets Epidemiology of HIV in Iran
Current HIV Research Meet Our Associate Editor
Current Drug Metabolism Structure-based Drug Design Targeting Biosynthesis of Isoprenoids: A Crystallographic State of the Art of the Involved Enzymes
Current Protein & Peptide Science Microbial Immune Evasion Employing Suppressor of Cytokine Signaling (SOCS) Proteins
Inflammation & Allergy - Drug Targets (Discontinued)